Biocompatibility and levofloxacin delivery of mesoporous materials.

@article{Cicundez2013BiocompatibilityAL,
  title={Biocompatibility and levofloxacin delivery of mesoporous materials.},
  author={M{\'o}nica Cicu{\'e}ndez and Isabel Izquierdo-Barba and Mar{\'i}a Teresa Portol{\'e}s and Mar{\'i}a Vallet-Reg{\'i}},
  journal={European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V},
  year={2013},
  volume={84 1},
  pages={115-24}
}
A comparative study of mesoporous matrices designed for both drug-loading methods, impregnation (IP) and surfactant-assisted drug loading (also denoted as one-pot, OP), has been carried out evaluating their physicochemical characteristics, cell response, drug delivery profiles, and antibacterial activity. Surfactant-free (calcined) and surfactant-templated (non-calcined) mesoporous silica have been used as IP and OP starting matrices, respectively. Both non-calcined and calcined matrices do not… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 49 references

Ciplofloaxin , lomefloxacin or levofloxacin as treatment for cronic osteomyelitis

  • M. T. Newman Greenberg, S. Shariaty, R. W. Pector
  • Int . J . Pharmaceut .
  • 2012

Mesoporous silica nanoparticles: their projection in nanomedicine

  • M. Vallet-Regi
  • ISRN Mater. Sci.
  • 2012
2 Excerpts

Similar Papers

Loading similar papers…